Similar to our research, Liu et al. [30] constructed a panel of 7 DEG signatures consisting of PHLDA2, GGH, ESPL1, FAM184A, KIAA1644, ESPL1, and TRPM4 to predict the prognosis of endometrial cancer. The gene discussed is PHLDA2; the disease is endometrial cancer.